Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

NCT03881488

Conditions
Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +32 more
Locations
  • Ocala Oncology Center Ocala, Florida, United States
  • Hematology Oncology Associates Of The Treasure Coast Port Saint Lucie, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment

NCT01298323

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
Locations
  • Investigational Site Number : 301 St Leonards, New South Wales, Australia
  • Investigational Site Number 301 St Leonards, Australia
  • Investigational Site Number 401 Vienna, Austria
  • Investigational Site Number : 401 Vienna, Austria
View all 66 locations
View Trial Details

Related conditions